Stifel Financial Corp Biotechnology

Stifel Financial Corp

$93.7 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
TCRX T Scan Therapeutics, Inc.	$29.3M	$331,000 0.0% of portfolio	109,700	Q4 2024 Added 10.66%
RCKT Rocket Pharmaceuticals, Inc.	$577M	$257,000 0.0% of portfolio	20,463	Q4 2024 Added 1.84%
NKTX Nkarta, Inc.	$103M	$226,000 0.0% of portfolio	90,811	Q4 2024 Added 11.49%
GERN Geron Corp	$533M	$218,000 0.0% of portfolio	61,658	Q4 2024 Added 29.87%
CUE Cue Biopharma, Inc.	$26.2M	$217,000 0.0% of portfolio	211,361	Q4 2024 Added 8.82%
ABCL Ab Cellera Biologics Inc.	$744M	$209,000 0.0% of portfolio	71,514	Q4 2024 Reduced 4.41%
CDMO Avid Bioservices, Inc.	$776M	$203,000 0.0% of portfolio	16,512	Q4 2024 Reduced 2.25%
RNA Avidity Biosciences, Inc.	$1.7B	$202,000 0.0% of portfolio	6,949	Q4 2024 Reduced 13.27%
CDXS Codexis, Inc.	$151M	$198,000 0.0% of portfolio	41,673	Q4 2024 Reduced 75.8%
RPTX Repare Therapeutics Inc.	$57.5M	$117,000 0.0% of portfolio	89,500	Q4 2024 Added 73.11%
VYGR Voyager Therapeutics, Inc.	$136M	$114,000 0.0% of portfolio	20,142	Q4 2024 Added 0.33%
PGEN Precigen, Inc.	$314M	$101,000 0.0% of portfolio	90,857	Q4 2024 Added 182.16%
ALT Altimmune, Inc.	$257M	$94,000 0.0% of portfolio	13,103	Q4 2024 Reduced 26.19%
CABA Cabaletta Bio, Inc.	$37.1M	$91,000 0.0% of portfolio	41,626	Q4 2024 New
MGNX Macrogenics Inc	$103M	$84,000 0.0% of portfolio	25,861	Q4 2024 Reduced 35.17%
LXRX Lexicon Pharmaceuticals, Inc.	$125M	$83,000 0.0% of portfolio	112,853	Q4 2024 Added 117.04%
CGEN Compugen LTD	$134M	$80,000 0.0% of portfolio	52,290	Q4 2024 Added 0.43%
ALDX Aldeyra Therapeutics, Inc.	$155M	$73,000 0.0% of portfolio	14,756	Q4 2024 Reduced 8.39%
SAGE Sage Therapeutics, Inc.	$433M	$69,000 0.0% of portfolio	12,808	Q4 2024 Added 6.32%
XFOR X4 Pharmaceuticals, Inc	$259M	$58,000 0.0% of portfolio	75,607	Q4 2024 Reduced 38.25%
CCCC C4 Therapeutics, Inc.	$80.2M	$48,000 0.0% of portfolio	13,361	Q4 2024 Reduced 52.98%
TRVI Trevi Therapeutics, Inc.	$401M	$46,000 0.0% of portfolio	11,015	Q4 2024 Reduced 2.63%
NUVB Nuvation Bio Inc.	$489M	$45,000 0.0% of portfolio	17,070	Q4 2024 Added 10.77%
RLAY Relay Therapeutics, Inc.	$400M	$42,000 0.0% of portfolio	10,200	Q4 2024 New
ABSI Absci Corp	$271M	$37,000 0.0% of portfolio	14,278	Q4 2024 Reduced 25.45%
FATE Fate Therapeutics Inc	$124M	$23,000 0.0% of portfolio	14,175	Q4 2024 Reduced 41.17%
CLSD Clearside Biomedical, Inc.	$52.4M	$23,000 0.0% of portfolio	23,944	Q4 2024 Added 4.36%
RANI Rani Therapeutics Holdings, Inc.	$27.7M	$20,000 0.0% of portfolio	14,684	Q4 2024 Reduced 94.56%
SANA Sana Biotechnology, Inc.	$361M	$16,000 0.0% of portfolio	10,397	Q4 2024 Added 1.29%
MCRB Seres Therapeutics, Inc.	$1.15B	$16,000 0.0% of portfolio	20,000	Q4 2023 New
VXRT Vaxart, Inc.	$55.7M	$16,000 0.0% of portfolio	25,090	Q4 2024 Reduced 8.73%
ADAP Adaptimmune Therapeutics PLC	$44.1M	$14,000 0.0% of portfolio	26,469	Q4 2024 Reduced 4.16%
FGEN Fibrogen Inc	$31.9M	$14,000 0.0% of portfolio	27,031	Q4 2024 Reduced 42.53%
CVM Cel Sci Corp	$12.6M	$8,000 0.0% of portfolio	20,000	Q4 2024 Reduced 0.04%
AMRN Amarin Corp Plcuk	$4.34B	$7,000 0.0% of portfolio	16,517	Q4 2024 Reduced 3.55%
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	13,759	Q4 2024 Added 0.09%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.